Keywords: CI; confidence interval; H2RA; histamine-2 receptor antagonist; PPI; proton pump inhibitor; SIR; standardised incidence ratio; Gastrointestinal neoplasms; Esophageal neoplasms; Gastroesophageal reflux; Gastric acid; Proton pump inhibitors;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: GERD; gastroesophageal reflux disease; NERD; non-erosive disease; ERD; erosive disease; LES; lower esophageal sphincter; PPI; proton pump inhibitor; H2RA; histamine receptor antagonists; ATPase; adenosine 5â²triphosphatase; EE; erosive esophagitis; NNT;
Keywords: Epidemiology; Reflux Treatment; Cardiovascular Disease; Drug; BMI; body mass index; CI; confidence interval; GERD; gastroesophageal reflux disease; GI; gastrointestinal; H2RA; histamine-2 receptor antagonist; HPFS; Health Professionals Follow-up Study; HR
Keywords: Acid-Related Diseases; Side-Effects; Treatment; Epidemiology; CI; confidence interval; DDD; defined daily dose; H2RA; histamine-2 receptor antagonists; LSADT; Longitudinal Study of Aging Danish Twins; MADT; Middle-Aged Danish Twin study; PPI; proton pump
Keywords: Acid-Suppressive Therapy; Heart Disease; Pharmacoepidemiology; Comparative Safety; ADMA; asymmetrical dimethylarginine; CI; confidence interval; FDAs; Food and Drug Administration; GERD; gastroesophageal reflux disease; H2RA; histamine-2 receptor antagoni
Keywords: pediatric; gastroenterology; endoscopy; hemorrhage; readmission; outcomes; complications; ED; Emergency department; ED-IP; 30-day inpatient readmission through the ED; GIB; Gastrointestinal bleed; H2RA; Histamine H2 receptor antagonist; ICD-9; Internation
Keywords: Acid Suppression; Intestinal Permeability; Critical Care; Bacteremia; aHR; adjusted hazard ratio; BSI; bloodstream infection; CCI; Charlson comorbidity index; CI; confidence interval; GI; gastrointestinal; H2RA; histamine-2 receptor antagonist; ICD; Inter
Keywords: Cancer Detection; Screening; Population; Tumorigenesis; BE; Barrett's esophagus; EAC; esophageal adenocarcinoma; GEJ; gastroesophageal junction; HGD; high-grade dysplasia; H2RA; histamine receptor antagonist; IM; intestinal metaplasia; LGD; low-grade dy
Keywords: Acid Suppressing; Medications; Iron Deficiency; Epidemiology; BE; Barrett's esophagus; GERD; gastroesophageal reflux disease; H2RA; histamine-2 receptor agonist; ICD-9; International Classification of Disease, 9th revision; KPNC; Kaiser Permanente North
Keywords: Epidemiology; Drug; Brain; Alzheimer's; AD; Alzheimer's disease; CI; confidence interval; H2RA; H2 receptor antagonist; HR; hazard ratio; PPI; proton pump inhibitor;
Keywords: Acid-related diseases; Gastric acid secretion; H2 receptor; Peptic ulcer; Potassium-competitive acid blocker; Proton pump inhibitor; ARD; acid-related disease; CCK2R; cholecystokinin-2 receptor; ECL; enterochromaffin-like; H2RA; histamine H2 receptor anta
Keywords: AT; antithrombotic therapy; CI; confidence interval; ESD; endoscopic submucosal dissection; H2RA; histamine-2 receptor antagonist; OR; odds ratio; PPB; postprocedural bleeding; PPI; proton pump inhibitor; RCT; randomized controlled trial; SLE; second-look
Keywords: Stomach; Intestine; Peptic Ulcer; Small Bowel; Colon; Side Effect; Complication; APA; antiplatelet agent; ASA; low-dose aspirin; CI; confidence interval; GI; gastrointestinal; H2RA; H2 receptor antagonist; LGIB; lower gastrointestinal bleeding; NSAID; non
Keywords: Gastroesophageal Reflux Disease (GERD); Measure of Quality of Care; RAND/UCLA Appropriateness Methodology (RAM); Proton Pump Inhibitor (PPI); ACG; American College of Gastroenterology; AGA; American Gastroenterological Association; AHRQ; Agency for Health
Keywords: Anticoagulant; Drug Side Effect; PPI; H2RA; AF; atrial fibrillation; CDARS; Hong Kong Clinical Data Analysis and Reporting System; CI; confidence interval; CMS; Clinical Management System; GIB; gastrointestinal bleeding; HA; Hospital Authority; HKW; Hong
Keywords: Aspirin; Barrett's Esophagus; Cancer Outcomes; Metformin; NSAIDs; Statins; Survival; CI; confidence interval; COX-2; cyclooxygenase-2; H2RA; histamine receptor antagonist; NSAID; nonsteroidal anti-inflammatory drug; PPI; proton pump inhibitor;
Keywords: CDI; Clostridium difficile infection; H2RA; Histamine-2 receptor antagonist; ICD-9-CM; International Classification of Diseases, Ninth Revision, Clinical Modification; MHS; Military health system; PPI; Proton pump inhibitor; RI; Relative incidence; SCCS;
Keywords: Newly Diagnosed Barrett's Esophagus Study; Bacteria; Stomach; BE; AAVAMC; Ann Arbor Veterans Affairs Medical Center; cagA; cytotoxin-associated gene A; CI; confidence interval; CRC; colorectal cancer; GERD; gastroesophageal reflux disease; GERQ; Gastroeso
Extraesophageal Symptoms and Diseases Attributed to GERD: Where is the Pendulum Swinging Now?
Keywords: Laryngitis; Cough; Asthma; Reflux Testing and Treatment; GERD; gastroesophageal reflux disease; H2RA; histamine receptor antagonist; LPR; laryngopharyngoreflux; MI; mucosal impedance; PPI; proton pump inhibitor;
Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin
Keywords: Acid-Suppressive Drugs; Hemorrhage; ASA; Antiplatelet; CI; confidence interval; GI; gastrointestinal; H2RA; H2-receptor antagonists; PPI; proton pump inhibitor;
Histamine H2 Receptor Antagonists, Left Ventricular Morphology, and Heart Failure Risk: The MESA Study
Keywords: cardiac magnetic resonance imaging; heart failure; prevention; BMI; body mass index; CI; confidence interval; CMR; cardiac magnetic resonance imaging; CVD; cardiovascular disease; H2RA; histamine H2 receptor antagonists; HF; heart failure; HFpEF; heart fa
Temporal trends in dietary supplement prescriptions of United States military service members suggest a decrease in pyridoxine and increase in vitamin D supplements from 2005 to 2013
Keywords: Multivitamins; Vitamins; Minerals; Antacids/absorbents; Iron preparations; Cathartics/laxatives; AI; Adequate Intake; AHFS; American Hospital Formulary System; AFHSB; Armed Forces Health Surveillance Branch; COX; Cyclooxygenase; DS; Dietary Supplement; GC
Chronic Cough Due to Gastroesophageal Reflux in Adults: CHEST Guideline and Expert Panel Report
Keywords: cough; evidence-based medicine; gastroesophageal reflux disease; guidelines; ACE; angiotensin-converting enzyme; CHEST; American College of Chest Physicians; GER; gastroesophageal reflux; GERD; gastroesophageal reflux disease; H2RA; histamine-2 receptor a
Acid Suppression and the Risk of Clostridium difficile Infection
Keywords: CA-CDI; Community acquired CDI; CDAD; Clostridium difficile-associated disease; CDI; Clostridium difficile infection; H2RA; Histamine type 2 receptor antagonist; PPI; Proton pump inhibitor;
Cost-Effectiveness Analysis: Stress Ulcer Bleeding Prophylaxis with Proton Pump Inhibitors, H2 Receptor Antagonists
Keywords: cost-effectiveness; H2RA; proton pump inhibitors; stress ulcer bleeding;
Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection
Keywords: CDI; Clostridium difficile infection; H2RA; histamine 2 receptor antagonist; ICU; intensive care unit; OR; odds ratio; PPI; proton pump inhibitor; SUP; stress ulcer prophylaxis;
Reported Side Effects and Complications of Long-term Proton Pump Inhibitor Use: Dissecting the Evidence
Keywords: BMD; bone mineral density; CAP; community-acquired pneumonia; CI; confidence interval; FDA; Food and Drug Administration; GI; gastrointestinal; H2RA; histamine 2-receptor antagonist; IBS; irritable bowel syndrome; OR; odds ratio; PPI; proton pump inhibi
Waist-to-Hip Ratio, but Not Body Mass Index, Is Associated With an Increased Risk of Barrett's Esophagus in White Men
Keywords: Visceral Obesity; Epidemiologic Study; Veterans Affairs; Risk Factors; BE; Barrett's esophagus; BMI; body mass index; CI; confidence interval; EGD; esophagogastroduodenoscopy; GERD; gastroesophageal reflux disease; H2RA; histamine-2-receptor antagonist;
Analysis of Upper Gastrointestinal Adverse Events Among Patients Given Dabigatran in the RE-LY Trial
Keywords: Upset Stomach; Clinical Trial; Post Hoc Analysis; Side Effect; Toxicity; AE; adverse event; CI; confidence interval; FDA; Food and Drug Administration; GERD; gastroesophageal reflux disease; GI; gastrointestinal; H2RA; histamine-2 receptor-antagonist; Med
Co-prescription of Gastroprotective Agents and Their Efficacy in Elderly Patients Taking Nonsteroidal Anti-inflammatory Drugs: A Systematic Review of Observational Studies
Keywords: Anti-ulcer Agents; Peptic Ulcer; Seniors; Aspirin; CI; confidence interval; COX-2; cyclooxygenase-2; GI; gastrointestinal; H2RA; histamine-2 receptor antagonist; NS; nonselective; NSAID; nonsteroidal anti-inflammatory drug; OR; odds ratio; PPI; proton pum
Over-Prescription of Acid-Suppressing Medications in Infants: How It Came About, Why It's Wrong, and What to Do About It
Keywords: DTC; Direct-to-consumer; GER; Gastroesophageal reflux; GERD; Gastroesophageal reflux disease; H2RA; Histamine-2-receptor antagonist; PPI; Proton pump inhibitor;
Gastroprotective Therapy Does Not Improve Outcomes of Patients With Helicobacter pylori-Negative Idiopathic Bleeding Ulcers
Keywords: Proton Pump Inhibitor (PPI); H2RA; Clinical Trial; Stomach; ASA; American Society of Anesthesiology; CI; confidence interval; GPA; gastroprotective agent; H2RA; histamine-2 receptor antagonist; IBD; inflammatory bowel disease; NSAID; nonsteriodal anti-inf
Increased Rate of Spontaneous Bacterial Peritonitis Among Cirrhotic Patients Receiving Pharmacologic Acid Suppression
Keywords: H2 Blocker; Stomach; Bacterial Infection; Hepatitis; CPT; Child-Pugh-Turcotte; H2RA; H2-receptor antagonist; PPI; proton pump inhibitor; SBP; spontaneous bacterial peritonitis;
Systematic Review: Patterns of Proton Pump Inhibitor Use and Adherence in Gastroesophageal Reflux Disease
Keywords: Medication Possession Ratio; Dosing Frequency; Concomitant Medication; Reflux Symptoms; Adherence; BE; Barrett's esophagus; CI; confidence interval; GERD; gastroesophageal reflux disease; H2RA; histamine-2 receptor antagonist; ICD-9; International Classif
Association Between Proton Pump Inhibitor Therapy and Clostridium difficile Infection in a Meta-Analysis
Keywords: Gastric Acid Suppression; Infectious Diarrhea; Systematic Analysis; Bacteria; CDI; Clostridium difficile infection; CI; confidence interval; H2RA; histamine 2 receptor antagonist; NNH; number needed to harm; OR; odds ratio; PPI; proton pump inhibitor;
Acid Suppressants Reduce Risk of Gastrointestinal Bleeding in Patients on Antithrombotic or Anti-Inflammatory Therapy
Keywords: Gastrointestinal Hemorrhage; Aspirin; Antiplatelet Agents; Side Effects; ASA; acetylsalicylic acid; CI; confidence interval; DAT; dual antiplatelet therapy; H2RA; histamine type 2 receptor antagonist; NSAID; nonsteroidal anti-inflammatory drug; PCP; prima
Original articleClinical endoscopyBleeding after percutaneous endoscopic gastrostomy is linked to serotonin reuptake inhibitors, not aspirin or clopidogrel
Keywords: ASGE; American Society for Gastrointestinal Endoscopy; H2RA; H2-receptor antagonist; ICU; intensive care unit; NNTH; number needed to harm; NSAID; nonsteroidal anti-inflammatory drug; OR; odds ratio; PEG; percutaneous endoscopic gastrostomy; PPB; post-PEG
Proton Pump Inhibitors for Gastroduodenal Damage Related to Nonsteroidal Anti-inflammatory Drugs or Aspirin: Twelve Important Questions for Clinical Practice
Keywords: CI; confidence interval; COX; cyclooxygenase; GI; gastrointestinal; GPA; gastroprotective agent; H2RA; H2-receptor antagonist; LDA; low-dose aspirin; NSAID; nonsteroidal anti-inflammatory drug; OR; odds ratio; PPI; proton pump inhibitor; PUB; peptic ulcer
Endoscopic Therapy for Bleeding Ulcers: An Evidence-Based Approach Based on Meta-Analyses of Randomized Controlled Trials
Keywords: BPEC; bipolar electrocoagulation; CI; confidence interval; HP; heater probe; H2RA; histamine2-receptor antagonist; NNT; number-needed-to-treat; PPI; proton pump inhibitor; RR; relative risk;
The Utility of Intraluminal Impedance in Patients With Gastroesophageal Reflux Disease-Like Symptoms But Normal Endoscopy and 24-Hour pH Testing
Keywords: GERD; gastroesophageal reflux disease; H2RA; H2 receptor antagonist; MII; multichannel intraluminal impedance; PPI; proton pump inhibitor; SAP; Symptom Association Probability; SI; Symptom Index;
Efficacy of Conservative Therapy as Taught in the Primary Care Setting for Symptoms Suggesting Infant Gastroesophageal Reflux
Keywords: GERD; Gastroesophageal reflux disease; H2RA; Histamine-2 receptor antagonist; I-GERQ-R; Infant Gastroesophageal Reflux Questionnaire-Revised;
Persistent Heartburn in a Patient on Proton-Pump Inhibitor
Keywords: DGER; duodenogastroesophageal reflux; EE; erosive esophagitis; GERD; gastroesophageal reflux disease; H2RA; H2 receptor antagonist; MII; multichannel intraluminal impedance; NAB; nocturnal acid breakthrough; NERD; nonerosive reflux disease; PPI; proton-pu
American Gastroenterological Association Institute Technical Review on the Management of Gastroesophageal Reflux Disease
Keywords: AGA; American Gastroenterological Association; GERD; gastroesophageal reflux disease; H2RA; histamine2 receptor antagonist; PPI; proton pump inhibitor; USPSTF; US Preventive Services Task Force;
Determinants of Gastroesophageal Reflux Disease in Adults With a History of Childhood Gastroesophageal Reflux Disease
Keywords: BMI; body mass index; CPT; Current procedural terminology; GERD; gastroesophageal reflux disease; H2RA; histimine2 receptor antagonist; OCP; oral contraceptive pill; PPI; proton pump inhibitor;
Use of Acid-Suppressing Drugs and the Risk of Bacterial Gastroenteritis
Keywords: GE; gastroenteritis; GP; general practitioner; PPI; proton pump inhibitors; H2RA; H2 receptor antagonists; RR; relative risk;
Characteristics of Children Receiving Proton Pump Inhibitors Continuously for Up to 11 Years Duration
Keywords: ALT; Alanine aminotransferase; AST; Aspartate aminotransferase; BCCH; British Columbia Children's Hospital; GERD; Gastroesophageal reflux disease; GI; Gastrointestinal; H2Ra; Histamine-2-receptor antagonist; IQR; Interquartile range; PPI; Proton pump in
Chronic Proton Pump Inhibitor Therapy and the Risk of Colorectal Cancer
Keywords: CI; confidence interval; CRC; colorectal cancer; DDD; defined daily dose; GPRD; General Practice Research Database; HRT; hormone replacement therapy; H2RA; histamine 2 receptor antagonist; OR; odds ratio; PPI; proton pump inhibitor;
Proton Pump Inhibitor Therapy for Peptic Ulcer Bleeding: Cochrane Collaboration Meta-analysis of Randomized Controlled Trials
Keywords: CI; confidence interval; H2RA; histamine2-receptor antagonist; IV; intravenous; NNT; number needed to treat; OR; odds ratio; PPI; proton pump inhibitor; RCT; randomized controlled trial;
Complications and Antireflux Medication Use After Antireflux Surgery
Keywords: GERD; gastroesophageal reflux disease; H2RA; H2 receptor antagonist; ICD-9-CM; International Classification of Diseases, 9th Revision, Clinical Modification; PPI; proton pump inhibitor; PTF; patient treatment file; VA; Department of Veterans Affairs;
Proton Pump Inhibitors and Acute Interstitial Nephritis
Keywords: AIN; acute interstitial nephritis; ARF; acute renal failure; CKD; chronic kidney disease; GFR; glomerular filtration rate; H2RA; H2 receptor antagonist(s); PPI; proton pump inhibitor(s); TGA; Therapeutics Goods Administration;